Acquired EML4-ALK Fusion and EGFR C797S in Cis Mutation As Resistance Mechanisms to Osimertinib in a Non-Small Cell Lung Cancer Patient with EGFR L858R/T790M
ANTI-CANCER DRUGS（2023）
关键词
C797S mutation,epidermal growth factor receptor tyrosine kinase inhibitors,EML4-ALK,osimertinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要